Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder
Clinical trial NCT00311376 · COMPLETED
Trial details
- NCT number
- NCT00311376
- Sponsor
- Allergan
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2010-05-01
- Enrollment
- 416
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.